Compare IMCR & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMCR | LZB |
|---|---|---|
| Founded | 2008 | 1927 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2016 | 1994 |
| Metric | IMCR | LZB |
|---|---|---|
| Price | $28.63 | $37.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $66.33 | $39.00 |
| AVG Volume (30 Days) | 304.3K | ★ 369.4K |
| Earning Date | 05-07-2026 | 06-16-2026 |
| Dividend Yield | N/A | ★ 2.75% |
| EPS Growth | ★ 30.39 | N/A |
| EPS | 0.25 | ★ 1.65 |
| Revenue | $249,428,000.00 | ★ $2,349,433,000.00 |
| Revenue This Year | $14.57 | $1.89 |
| Revenue Next Year | $8.21 | $2.09 |
| P/E Ratio | $117.72 | ★ $22.70 |
| Revenue Growth | ★ 43.05 | N/A |
| 52 Week Low | $27.56 | $29.03 |
| 52 Week High | $40.71 | $42.39 |
| Indicator | IMCR | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 44.87 | 64.98 |
| Support Level | $27.69 | $37.42 |
| Resistance Level | $31.56 | $39.95 |
| Average True Range (ATR) | 1.14 | 1.00 |
| MACD | 0.08 | 0.24 |
| Stochastic Oscillator | 22.02 | 82.34 |
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.